No abstract available
MeSH terms
-
Disease Progression
-
Fluorodeoxyglucose F18 / analysis*
-
Hodgkin Disease / diagnostic imaging*
-
Hodgkin Disease / therapy*
-
Humans
-
Immune System
-
Immunotherapy*
-
Nivolumab / therapeutic use*
-
Positron Emission Tomography Computed Tomography*
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors
-
Recurrence
-
Retrospective Studies
-
Treatment Outcome
Substances
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
Fluorodeoxyglucose F18
-
Nivolumab